Presentation Premature Clopidogrel Discontinuation After DES Placement in a Large Urban Safety-Net Hospital Presenter: H. Khalili December 09, 2015 REGISTER for free or LOG IN to view this content CAD Pharma DES/BRS/DCB Factoid Up Next Presentation Effect of Availability of TAVR on Clinical Practice Presenter: Jochen Rein?hl December 15, 2015 More slides + Presentation Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD Presenter: PA. Gurbel December 16, 2015 Presentation Enrollment Volume Effect on Risk Factor Control and Outcomes in the SAMMPRIS Trial Presenter: David Chiu December 17, 2015 We Recommend
Presentation Effect of Availability of TAVR on Clinical Practice Presenter: Jochen Rein?hl December 15, 2015
Presentation Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD Presenter: PA. Gurbel December 16, 2015
Presentation Enrollment Volume Effect on Risk Factor Control and Outcomes in the SAMMPRIS Trial Presenter: David Chiu December 17, 2015